Cochrane and Meta-Analysis Verdicts on 20 Popular Supplements: The Blunt Version (2026)

Most popular supplements do less than the industry implies and more than pure skeptics admit. The trick is knowing which is which. This is a blunt summary of Cochrane reviews and high-quality meta-analyses on 20 of the most widely sold supplements. Some (zinc for cold duration, melatonin for jet lag, probiotics for antibiotic-associated diarrhea, St. John's Wort for mild-to-moderate depression) have real effect sizes in defined populations. Others (vitamin C for cold prevention in the general public, ginkgo for dementia, multivitamins for mortality) are null in pooled evidence. Evidence is a moving target — this guide reflects the most recent widely cited reviews and notes where results are fragile.

Cochrane reviews remain the gold standard for systematic evidence synthesis because of their rigorous protocols, bias-risk assessment, and update cycle. For some supplements, the most recent Cochrane review is a few years old; we note where major meta-analyses since then have updated or challenged the conclusion.

The master table

Supplement	Cochrane / meta-analysis verdict	Effect size	Who benefits most
Vitamin D	Null for all-cause mortality (pooled); mixed for falls/fractures	Small if any at population level	Deficient (<20 ng/mL), elderly, housebound
Vitamin C	Cold duration slightly shorter; prevention null except in stressed populations	8% shorter cold in adults	Athletes, cold-exposed workers
Zinc (lozenges)	Shorter common cold duration	~2 days shorter if started within 24h	Anyone catching a cold, within 24h
Echinacea	Null pooled for cold treatment/prevention	None reliably	Unclear
Calcium + vitamin D	Mixed for fractures; small benefit in institutionalized elderly	Small absolute risk reduction	Elderly, low-intake populations
Omega-3 (fish oil)	Small to null in primary CVD prevention (Abdelhamid 2020); triglyceride-lowering robust	TG: -15 to 30%; CV events: small	High-triglyceride, secondary prevention
Probiotics	Positive for antibiotic-associated diarrhea and pediatric acute diarrhea; modest for IBS	AAD: NNT ~13; IBS: modest	On antibiotics; some IBS patients
Glucosamine	Mixed; some formulations modest in OA	Small to moderate, variable	Knee OA, crystalline glucosamine sulfate
Multivitamin	Null for all-cause mortality (PHS II, SU.VI.MAX)	None for mortality	Nutrient-inadequate individuals
Melatonin	Positive for jet lag; modest for sleep onset latency	Jet lag: clear; insomnia: -7 min latency	Jet-lag travelers, delayed sleep phase
SAMe	Modest for depression vs placebo; similar to tricyclics	Moderate effect	Mild-moderate depression (clinical supervision)
St. John's Wort	Positive for mild-to-moderate depression	Comparable to some SSRIs for mild-moderate	Mild-moderate depression (interactions major)
Garlic	Small BP reductions	~4 mmHg systolic	Mildly hypertensive
Ginkgo biloba	Null for dementia prevention (GEM trial)	None reliably	Limited
Magnesium	Modest BP and sleep benefit	~2 mmHg systolic	Deficient, hypertensive, insomnia
Iron	Modest for fatigue in non-anemic iron-deficient	Moderate in low-ferritin women	Non-anemic iron-deficient
CoQ10	Positive in chronic heart failure (Q-SYMBIO; note not Cochrane)	Moderate	CHF patients (adjunct to standard care)
Creatine	Consistent benefit for strength/LBM with training	~1-2 kg LBM over 12 weeks	Resistance-trained and older adults
Melatonin for shift work	Modest improvement in daytime sleep	~20 min longer daytime sleep	Shift workers
Vitamin E (alpha-tocopherol alone)	Null or slight harm at high doses (SELECT, Miller meta-analysis)	None or negative	Not recommended general use

The verdicts, one by one

Vitamin D

Pooled RCT data (e.g., VITAL trial, Cochrane reviews) finds little benefit for all-cause mortality, cancer incidence, or cardiovascular events in generally replete adults. Benefit for falls and fractures is mixed, with signals in institutionalized elderly.

Who benefits most: people with 25(OH)D below 20 ng/mL, elderly, housebound, high-latitude winters. Who probably doesn't: replete healthy adults chasing additional benefits.

Vitamin C

Hemilä and Chalker's Cochrane review on vitamin C and the common cold shows regular supplementation slightly shortens cold duration (about 8% in adults, 14% in children). Routine prevention of incidence is null in general populations; a reduction in incidence has been observed in people under acute physical stress (soldiers, marathoners, subarctic workers).

Zinc

Cochrane reviews on zinc lozenges for the common cold consistently find shorter duration if started within 24 hours of symptom onset, on the order of one to two days. Taste and nausea are common side effects; long-term high-dose use can cause copper deficiency.

Echinacea

Cochrane review on echinacea for cold prevention or treatment found no reliable effect pooled across preparations.

Calcium plus vitamin D

Evidence is mixed. Benefit in fracture risk is most evident in institutionalized elderly and in low-calcium-intake populations. In generally healthy community-dwelling adults with adequate intake, the marginal benefit is small.

Omega-3

Abdelhamid et al.'s 2020 Cochrane review on omega-3 for cardiovascular disease concluded that marine omega-3 has little or no effect on all-cause mortality and modest at best effects on CV events in primary prevention. The REDUCE-IT trial (icosapent ethyl, 4 g/day) showed larger benefit in high-triglyceride secondary-prevention populations, but this is prescription EPA, not typical fish oil dosing. Triglyceride-lowering itself is a robust and consistent effect.

Probiotics

Cochrane reviews are positive for antibiotic-associated diarrhea prevention (particular strains including Saccharomyces boulardii and Lactobacillus rhamnosus GG) and for pediatric acute infectious diarrhea (modest). IBS evidence is modest and strain-specific. Broad "gut health" claims far outrun the evidence.

Glucosamine

The evidence is genuinely mixed. Pharmaceutical-grade crystalline glucosamine sulfate (used in European trials) has shown modest symptomatic benefit in knee osteoarthritis; glucosamine hydrochloride commonly sold in the U.S. has weaker evidence. The GAIT trial was largely null except in a moderate-to-severe pain subgroup.

Multivitamin

The Physicians' Health Study II and SU.VI.MAX long-term trials showed no reduction in all-cause mortality with multivitamin use. Benefit is most plausible in individuals with documented nutrient inadequacies rather than healthy populations.

Melatonin

Cochrane evidence for jet lag is clearly positive, particularly for eastward travel across multiple time zones. For primary insomnia in healthy adults, melatonin shortens sleep onset latency by a small amount (roughly 7 to 10 minutes) — real but modest. For delayed sleep-phase disorder, the effect is larger.

SAMe and St. John's Wort

Both have meta-analytic support for mild-to-moderate depression. St. John's Wort (Linde et al., Cochrane) performs comparably to some SSRIs for mild-to-moderate depression in older trials, though interaction risk (serotonin syndrome, reduced efficacy of oral contraceptives, warfarin, immunosuppressants) is substantial and requires medical supervision.

Garlic

Meta-analyses of aged garlic extract and standardized preparations show small blood pressure reductions, approximately 4 mmHg systolic, in mildly hypertensive populations.

Ginkgo biloba

The GEM (Ginkgo Evaluation of Memory) trial and subsequent meta-analyses found no significant benefit for dementia prevention or cognitive decline in older adults.

Magnesium

Meta-analyses show modest blood pressure reductions (~2 mmHg systolic) and small improvements in sleep quality in deficient populations. Form matters: glycinate and citrate are better tolerated than oxide, which is poorly absorbed.

Iron

In non-anemic but iron-deficient (low ferritin) individuals, particularly menstruating women, iron supplementation shows modest improvements in fatigue measures in several trials. Frank anemia warrants clinical evaluation.

CoQ10

The Q-SYMBIO trial (Mortensen et al., note this is not a Cochrane review) suggested reduced major adverse cardiovascular events in chronic heart failure with CoQ10 as adjunct to standard care. Broader claims (general energy, blood pressure) have weaker support.

Vitamin E (isolated high dose)

Miller et al.'s meta-analysis raised concerns about high-dose alpha-tocopherol supplementation and all-cause mortality; the SELECT trial also found increased prostate cancer with isolated alpha-tocopherol. High-dose isolated vitamin E is not recommended as general supplementation.

Creatine

Not a typical Cochrane topic, but very well-supported by meta-analyses. Consistent benefit for strength, lean body mass, and high-intensity performance. Emerging evidence in older adults for sarcopenia adjunct and possible cognitive effects in stressed conditions.

How to use this table

Match evidence to goal, not to marketing

If your goal is cold duration, zinc started within 24 hours has real support. If your goal is cold prevention in a desk-job lifestyle, the evidence is thin. If your goal is triglyceride reduction, omega-3 is reliable; if your goal is primary prevention of heart attacks in a low-risk adult, the effect is small.

The 80/20 evidence-based stack

For most healthy adults, the core evidence-supported picks converge on a short list: vitamin D (if deficient), omega-3 (especially if triglycerides are high), magnesium (if deficient or mildly hypertensive), creatine (if training), and a foundational multivitamin only if diet is inadequate.

Nutrola and evidence-aligned stacks

Nutrola tracks 100+ nutrients, supplement intake, and biomarker data in one place at €2.50 per month with zero ads. Nutrola Daily Essentials ($49/month, lab tested, EU certified, 100% natural) is built around foundational ingredients with meta-analytic or Cochrane-level support, rather than novelty ingredients with single-trial buzz.

Nutrola is reviewed 4.9 stars across 1,340,080 reviews.

Frequently Asked Questions

Do multivitamins reduce mortality?

No. Large long-term RCTs including PHS II and SU.VI.MAX found no reduction in all-cause mortality with multivitamins. Multivitamins may still benefit individuals with documented nutrient inadequacies; they are not a longevity intervention in healthy populations.

Is vitamin D worthless?

No. Vitamin D is genuinely useful for people with deficiency, institutionalized elderly, and fall risk. For replete healthy adults chasing extra benefits, the marginal effect on pooled mortality or disease outcomes is small or null.

What is the best-evidence sleep supplement?

Melatonin for jet lag and delayed sleep phase is well-supported. For garden-variety insomnia, the effect on sleep onset latency is small (roughly 7 to 10 minutes). Magnesium has modest support. None of these compare to CBT for insomnia, which remains the first-line evidence-based treatment.

Should I take probiotics daily?

Routine daily probiotic use in healthy adults has limited evidence. Strain-specific probiotics during a course of antibiotics are well-supported for preventing antibiotic-associated diarrhea. Broad "gut health" claims outpace the research.

Is St. John's Wort as good as an SSRI?

For mild-to-moderate depression, meta-analyses suggest comparable efficacy to some SSRIs in head-to-head trials. However, St. John's Wort has major drug interactions (hormonal contraceptives, warfarin, immunosuppressants, and others) and should only be used under medical supervision.

Which supplements are a clear waste of money for most people?

In generally healthy adults, echinacea, ginkgo for cognition, high-dose isolated vitamin E, and most proprietary "detox" and "fat burner" blends have weak or null evidence. Individual cases may differ, but as general recommendations, these rank near the bottom.

Medical disclaimer

This article is for educational purposes and does not constitute medical advice. Evidence on supplements evolves; individual needs vary. Several of the supplements discussed (St. John's Wort, SAMe, CoQ10, berberine-class compounds, high-dose vitamin E) have significant drug interactions or clinical considerations. Speak with a qualified healthcare professional before starting, continuing, or stopping any supplement, especially if you have a medical condition or take prescription medication.

References

1. Abdelhamid AS, et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev.
2. Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev.
3. Singh M, Das RR. Zinc for the common cold. Cochrane Database Syst Rev.
4. Linde K, et al. St John's wort for major depression. Cochrane Database Syst Rev.
5. Herxheimer A, Petrie KJ. Melatonin for the prevention and treatment of jet lag. Cochrane Database Syst Rev.
6. Goldenberg JZ, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev.
7. Miller ER, et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med.
8. Mortensen SA, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO. JACC Heart Fail.
9. Kreider RB, et al. International Society of Sports Nutrition position stand: creatine supplementation. J Int Soc Sports Nutr.
10. DeKosky ST, et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial (GEM study). JAMA.